Severe hemophagocytic syndrome after intravesical BCG instillation [5]

American Journal of Medicine

Volumn 112, Issue 7, 2002, Pages 593-594

  Schleinitz, Nicolas ^a   Bernit, Emmanuelle ^a   Harle, Jean Robert ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CORTICOSTEROID; CYCLOSPORIN A; ETHAMBUTOL; IMMUNOGLOBULIN; ISONIAZID; PREDNISONE; PYRAZINAMIDE; RIFAMPICIN; VINBLASTINE;

BACTERIAL INFECTION; BLADDER TUMOR; BONE MARROW BIOPSY; CELL COUNT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG INSTILLATION; DRUG SAFETY; ERYTHROPHAGOCYTOSIS; HEMOPHAGOCYTIC SYNDROME; HEPATOMEGALY; HUMAN; LABORATORY TEST; LETTER; PARASITOSIS; PRIORITY JOURNAL; SEROLOGY; SYMPTOMATOLOGY; TUBERCULOSIS;

ADMINISTRATION, INTRAVESICAL; BCG VACCINE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; MALE; MIDDLE AGED; URINARY BLADDER NEOPLASMS;

EID: 0036092488     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01066-5     Document Type: Letter

References (5)

1. Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer
2. Hemophagocytic syndromes and infection
3. Tuberculosis-associated haemophagocytic syndrome: A report of two cases and a review of the literature
4. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis
5. Advances in the management of hemophagocytic lymphohistiocytosis